Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | REGN | ARGX | ||
| Company | Alnylam Pharmaceuticals | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 447.00 | 723.69 | 912.88 | ||
| High | 449.78 | 724.13 | 917.71 | ||
| Low | 423.45 | 701.74 | 899.63 | ||
| Latest | 430.02 | 703.26 | 900.76 | ||
| Change | -28.10 | -15.10 | -0.41 | ||
| % Change | -6.13% | -2.10% | -0.05% | ||
| Volume | 2,411,600 | 1,005,900 | 395,700 | ||
| 20-Day Average Volume | 1,032,875 | 1,159,875 | 346,370 | ||
| Previous Close | 458.12 | 718.36 | 901.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 451.10 | 724.93 | 907.67 | ||
| 20-Day Raw Stochastic | 16.34% | 37.16% | 58.82% | ||
| 20-Day Relative Strength | 42.96 | 54.26 | 59.54 | ||
| Weighted Alpha | +69.39 | +7.02 | +59.99 | ||
| Today's Opinion | 24% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 80% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 56% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.40% since 12/01/25 | -6.25% since 12/01/25 | +0.65% since 12/01/25 | ||
| Low | 423.45 on 12/08/25 | 701.74 on 12/08/25 | 891.09 on 12/05/25 | ||
| High | 479.79 on 12/03/25 | 747.00 on 12/02/25 | 934.62 on 12/03/25 | ||
| 1-Month | |||||
| %Chg | -2.86% since 11/07/25 | +6.95% since 11/07/25 | +5.40% since 11/07/25 | ||
| Low | 420.30 on 11/24/25 | 651.38 on 11/11/25 | 852.39 on 11/10/25 | ||
| High | 479.79 on 12/03/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 3-Month | |||||
| %Chg | -5.50% since 09/08/25 | +25.93% since 09/08/25 | +17.29% since 09/08/25 | ||
| Low | 417.00 on 11/05/25 | 541.00 on 10/13/25 | 698.92 on 09/25/25 | ||
| High | 495.55 on 10/20/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +42.94% since 06/06/25 | +42.59% since 06/06/25 | +53.73% since 06/06/25 | ||
| Low | 295.82 on 06/12/25 | 494.42 on 06/09/25 | 510.05 on 06/30/25 | ||
| High | 495.55 on 10/20/25 | 790.98 on 11/26/25 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 60,524,056 | 75,498,912 | 55,484,136 | ||
| Shares Outstanding, K | 132,114 | 105,099 | 61,569 | ||
| Annual Sales | 2,248,240,000 | 14,202,000,000 | 2,252,040,000 | ||
| Annual Net Income | -278,160,000 | 4,412,600,000 | 833,040,000 | ||
| Last Quarter Sales | 1,249,030,000 | 3,754,300,000 | 1,151,340,000 | ||
| Last Quarter Net Income | 251,080,000 | 1,460,000,000 | 344,260,000 | ||
| 60-Month Beta | 0.30 | 0.37 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.90 on 10/30/25 | 11.83 on 10/28/25 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 10/30/25 | 10/28/25 | 10/30/25 | ||
| Most Recent Dividend | N/A | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 11/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 2,023.22 | 19.71 | 70.03 | ||